Regional Anesthesia
DrugTransverse abdominal Plane(TAP) Block with long acting Exparel placed by a regional anesthesiologist.
NCT Number: NCT06617949
The purpose of this study is to investigate the efficacy of three different modalities of post-operative pain control in parturient with opioid use disorders. The investigators aim to determine whether the different approach utilized show better outcomes with pain management and if there are any association with reduction of symptoms of anxiety, depression, and overall well-being.
Interested in participating?
Request Info18 year–40 year
Female
Interventional
Early Phase 1
Froedtert Hospital, Milwaukee, Wisconsin, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transverse abdominal Plane(TAP) Block with long acting Exparel placed by a regional anesthesiologist.
This group will be administered epidural PCA as a modality for pain control post cesarian section
Epidural group will receive pain control via a local anesthetic intermediate bolus infusion
Time frame: immediately after the study intervention and up to post op day 2
Number of participants with significant change in pain assessment scores and any association with reduction of symptoms of anxiety, depression, and overall well-being.
Interested in participating?
Request InfoMedical College of Wisconsin
Other
Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications: Efficacy and Safety Outcomes.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07768007
Chemically-Induced Disorders, Mental Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT07804121
Chemically-Induced Disorders, HIV
Lexington, Kentucky, United States
View Trial DetailsNCT07028983
Behavior, Behavior, Addictive
Vienna, Austria
View Trial DetailsNCT07740395
Behavior, Behavior, Addictive
Providence, Rhode Island, United States
View Trial Details